Expression of serum amyloid A in human ovarian epithelial tumors: Implication for a role in ovarian tumorigenesis

Journal of Histochemistry and Cytochemistry

Volumn 58, Issue 11, 2010, Pages 1015-1023

  Urieli Shoval, Simcha ^a   Finci Yeheskel, Zvezdana ^a   Dishon, Shira ^a   Galinsky, Daliah ^a   Linke, Reinhold P ^b   Ariel, Ilana ^a   Levin, Mark ^a   Ben Shachar, Inbar ^a   Prus, Diana ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Reference Center of Amyloid Diseases   (Germany)

Author keywords

Ovarian epithelial tumors; Ovarian tumorigenesis; Serum amyloid A

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CA 125 ANTIGEN; SERUM AMYLOID A;

ADENOMA; ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; OVARIAN BORDERLINE TUMOR; OVARY CARCINOMA; OVARY METASTASIS; OVARY TUMOR; OVCAR 3 CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADULT; AGED; BLOOD; CARCINOMA; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; OVARY; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CA-125 ANTIGEN; CARCINOMA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; OVARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERUM AMYLOID A PROTEIN; YOUNG ADULT;

EID: 78149482140     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2010.956821     Document Type: Article

References (40)

1. Badolato R,Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Kelvin DJ, et al. (1994) Serum amyloid A is a chemoattractant: induction of migration, adhesion and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 180:203-209
2. Biran H, Friedman N, Neumann L, Pras M, Shainkin-Kestenbaum R (1986) Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis. J Clin Pathol 39:794-797 (Pubitemid 16069491)
3. Borgfeldt C, Hansson SR, Gustavsson B, Måsbäck A, Casslén B (2001) Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1). Int J Cancer 92:497-502 (Pubitemid 32319422)
4. Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351:2519-2529
5. Cocco E, Bellone S, El-Sahwi K, Cargnelutti M, Buza N, Tavassoli FA, Schwartz PE, et al. (2010) Serum amyloid A: a novel biomarker for endometrial cancer. Cancer 116:843-851
6. Cocco E, Bellone S, El-Sahwi K, Cargnelutti M, Casagrande F, Buza N, Tavassoli FA, et al. (2009) Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer. Br J Cancer 101:335-341
7. Edgell T, Martin-Roussety G, Barker G, Autelitano DJ, Allen D, Grant P, Rice GE (2010) Phase II biomarker trial of a multimarker diagnostic for ovarian cancer. J Cancer Res Clin Oncol 136:1079-1088
8. Findeisen P, Zapatka M, Peccerella T, Matzk H, Neumaier M, Schadendorf D, Ugurel S (2009) Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling. J Clin Oncol 27:2199-2208
9. Fleming JS, Beaugie CR, Haviv I, Chenevix-Trench G, Tan OL (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 247:4-21 (Pubitemid 43277703)
10. Furlaneto CJ, Campa A (2000) A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem Biophys Res Commun 268:405-408
11. Gutfeld O, Prus D, Ackerman Z, Dishon S, Linke RP, Levin M, Urieli- Shoval S (2006) Expression of serum amyloid A, in normal, dysplastic and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis. J Histochem Cytochem 54:63-73 (Pubitemid 43049416)
12. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW,Whang-Peng J, et al. (1983) Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res 43:5379-5389 (Pubitemid 14230154)
13. Helleman J, van der Vlies D, Jansen MP, Luider TM, van der Burg ME, Stoter G, Berns EM (2008) Serum proteomic patterns for ovarian cancer monitoring. Int J Gynecol Cancer 18:985-995
14. Jijon HB, Madsen KL, Walker JW, Allard B, Jobin C (2005) Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells. Eur J Immunol 35:718-726 (Pubitemid 40425527)
15. Kluve-Beckerman B, Drumm ML, BensonMD(1991) Nonexpression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol 10:651-661
16. Koga T, Torigoshi T, Morokawa S, Miyashita T, Maeda Y, Nakamura M, Komori A, et al. (2008) Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes. FEBS Lett 582:579-585
17. Kumon Y, Suehiro T, Hashimoto K, Nakatani K, Sipe JD (1999) Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells. J Rheumatol 26:785-790 (Pubitemid 29195663)
18. Landen CN, Birrer MJ, Sood AK (2008) Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 26:995-1005 (Pubitemid 351398093)
19. Lee HY, Kim MK, Park KS, Bae YH, Yun J, Park JI, Kwak JY, et al. (2005) Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochem Biophys Res Commun 330:989-998 (Pubitemid 40462183)
20. Lee MS, Yoo SA, Cho CS, Suh PG, Kim WU, Ryu SH (2006) Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J Immunol 177:5585-5594 (Pubitemid 44527633)
21. Linke RP (1984) Monoclonal antibodies against amyloid fibril protein AA. Production, specificity, and use for immunohistochemical localization and classification of AA-type amyloidosis. J Histochem Cytochem 32:322-328
22. Linke RP, Bock V, Valet G, Rothe G (1991) Inhibition of the oxidative burst response of N- formyl peptide-stimulated neutrophils by serum amyloid A protein. Biochem Biophys Res Commun 176:1100-1105
23. Liu DH, Wang XM, Zhang LJ, Dai SW, Liu LY, Liu JF, Wu SS, et al. (2007) Serum amyloid A protein: a potential biomarker correlated with clinical stage of lung cancer. Biomed Environ Sci 20:33-40
24. Meek RL, Urieli-Shoval S, Benditt EP (1994) Expression of apolipo-protein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci USA 91:3186-3190 (Pubitemid 24130200)
25. Michaeli A, Finci-Yeheskel Z, Dishon S, Linke RP, Levin M, Urieli- Shoval S (2008) Serum amyloid A enhances plasminogen activation: implication for a role in colon cancer. Biochem Biophys Res Commun 368:368-373
26. Migita K, Kawabe Y, Tominaga M, Origuchi T, Aoyagi T, Eguchi K (1998) Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest 78:535-539 (Pubitemid 28246977)
27. Moshkovskii SA, Serebryakova MV, Kuteykin-Teplyakov KB, Tikhonova OV, Goufman EI, Zgoda VG, Taranets IN, et al. (2005) Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. Proteomics 5:3790-3797
28. Mullan RH, Bresnihan B, Golden-Mason L, Markham T, O'Hara R, FitzGerald O, Veale DJ, et al. (2006) Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. Arthritis Rheum 54:105-114 (Pubitemid 43122193)
29. Paret C, Schön Z, Szponar A, Kovacs G (2009) Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome. Eur Urol 57:859-866
30. Rosenthal CJ, Sullivan LE (1979) Serum amyloid A to monitor cancer dissemination. Ann Intern Med 91:383-390
31. Singer G, Kurman RJ, Chang HW, Cho SK, Shih IeM (2002) Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol 160:1223-1228 (Pubitemid 34411626)
32. Uhlar CM, Burgess CJ, Sharp PM, Whitehead AS (1994) Evolution of the serum amyloid A (SAA) protein superfamily. Genomics 19:228-235 (Pubitemid 24059312)
33. Urieli-Shoval S, Cohen P, Eisenberg S, Matzner Y (1998) Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J Histochem Cytochem 46:1377-1384 (Pubitemid 28555406)
34. Urieli-Shoval S, Linke RP, Matzner Y (2000) Expression and function of serum amyloid A, a major acute phase protein, in normal and disease states. Curr Opin Hematol 7:64-69 (Pubitemid 30007690)
35. Urieli-Shoval S, Meek RL, Hanson RH, Eriksen N, Benditt EP (1994) Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am J Pathol 145:650-660 (Pubitemid 24285972)
36. Urieli-Shoval S, Shubinsky G, Linke RP, Fridkin M, Tabi I, Matzner Y (2002) Adhesion of human platelets to serum amyloid A. Blood 99:1224-1229 (Pubitemid 34547074)
37. Weinstein PS, Skinner M, Sipe JD, Lokich JJ, Zamcheck N, Cohen AS (1984) Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol 19:193-198 (Pubitemid 14171511)
38. Whitehead AS, deBeer MC, Steel DM, Rits M, Lelias JM, Lane WS, deBeer FC (1992) Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 267:3862-3867
39. Xu L, Badolato R, Murphy WJ, Longo DL, Anver M, Hale S, Oppenheim JJ, et al. (1995) A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J Immunol 155:1184-1190
40. Yokoi K, Shih LC, Kobayashi R, Koomen J, Hawke D, Li D, Hamilton SR, et al. (2005) Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer. Int J Oncol 27:1361-1369